146 related articles for article (PubMed ID: 1749204)
1. Thromboxane production and platelet aggregation in type 2 diabetes mellitus without vascular complications.
Ratzmann KP; Schimke E; Beitz A; Hildebrandt R; Taube C
Klin Wochenschr; 1991 Sep; 69(14):652-6. PubMed ID: 1749204
[TBL] [Abstract][Full Text] [Related]
2. Improvement of metabolic control and changes of fatty acid composition do not alter platelet aggregability and thromboxane production in type 2 diabetes mellitus.
Ratzmann KP; Schimke E; Beitz A; Hildebrandt R; Taube C
Horm Metab Res Suppl; 1992; 26():103-5. PubMed ID: 1490671
[TBL] [Abstract][Full Text] [Related]
3. The effect of dihomogammalinolenic acid on platelet aggregation and prostaglandin release, erythrocyte membrane fatty acids and serum lipids: evidence for defects in PGE1 synthesis and delta 5-desaturase activity in insulin-dependent diabetics.
Mikhailidis DP; Kirtland SJ; Barradas MA; Mahadeviah S; Dandona P
Diabetes Res; 1986 Jan; 3(1):7-12. PubMed ID: 2937601
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipid fatty acids and platelet function during continuous subcutaneous insulin infusion in type I diabetes.
Monnier LH; Rodier M; Gancel A; Crastes de Paulet P; Colette C; Piperno M; Crastes de Paulet J
Diabete Metab; 1987 Jun; 13(3):210-6. PubMed ID: 3301444
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane production in diabetes mellitus.
Altomonte L; Zoli A; Mangia A; Ghirlanda G; Manna R; Bertoli A; Greco AV
Ric Clin Lab; 1986; 16(4):539-42. PubMed ID: 3576051
[TBL] [Abstract][Full Text] [Related]
6. [Influence of metabolic and nutritional balance on platelet function in insulin-dependent diabetes].
Monnier L
Journ Annu Diabetol Hotel Dieu; 1984; ():351-9. PubMed ID: 6100381
[No Abstract] [Full Text] [Related]
7. Relationships between serum lipids, platelet membrane fatty acid composition and platelet aggregation in type 2 diabetes mellitus.
Rodier M; Colette C; Crastes de Paulet P; Crastes de Paulet A; Monnier L
Diabete Metab; 1993; 19(6):560-5. PubMed ID: 8026607
[TBL] [Abstract][Full Text] [Related]
8. Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status.
Véricel E; Januel C; Carreras M; Moulin P; Lagarde M
Diabetes; 2004 Apr; 53(4):1046-51. PubMed ID: 15047620
[TBL] [Abstract][Full Text] [Related]
9. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin E administration on platelet function in diabetes mellitus.
Kunisaki M; Umeda F; Inoguchi T; Watanabe J; Nawata H
Diabetes Res; 1990 May; 14(1):37-42. PubMed ID: 2134664
[TBL] [Abstract][Full Text] [Related]
11. Influence of a cod liver oil diet in healthy and insulin-dependent diabetic volunteers on fatty acid pattern, inhibition of prostacyclin formation by low density lipoprotein (LDL) and platelet thromboxane.
Beitz J; Schimke E; Liebaug U; Block HU; Beitz A; Honigmann G; Sziegoleit W; Müller G; Mest HJ
Klin Wochenschr; 1986 Sep; 64(17):793-9. PubMed ID: 3531705
[TBL] [Abstract][Full Text] [Related]
12. Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic control.
Davì G; Averna M; Catalano I; Barbagallo CM; Giovenco E; Carroccio A; Notarbartolo A; Strano A
Diabetes Res; 1989 Jan; 10(1):7-12. PubMed ID: 2667842
[TBL] [Abstract][Full Text] [Related]
13. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study.
Axelrod L; Camuso J; Williams E; Kleinman K; Briones E; Schoenfeld D
Diabetes Care; 1994 Jan; 17(1):37-44. PubMed ID: 8112187
[TBL] [Abstract][Full Text] [Related]
14. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
Chen SY; Yu BJ; Liang YQ; Lin WD
Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
[TBL] [Abstract][Full Text] [Related]
15. Effects of insulin therapy upon plasma lipid fatty acids and platelet aggregation in NIDDM with secondary failure to oral antidiabetic agents.
Rodier M; Colette C; Gouzes C; Michel F; Crastes de Paulet A; Monnier L
Diabetes Res Clin Pract; 1995 Apr; 28(1):19-28. PubMed ID: 7587908
[TBL] [Abstract][Full Text] [Related]
16. Possible relevance of lipid peroxidation and thromboxane production to the initiation and/or evolution of microangiopathy in non-hyperlipidemic type 2 diabetes mellitus.
Katoh K
Diabetes Res Clin Pract; 1992 Nov; 18(2):89-98. PubMed ID: 1478157
[TBL] [Abstract][Full Text] [Related]
17. Platelet hyperreactivity in hyperlipidaemia with specific reference to platelet lipids and fatty acid composition.
Chetty N; Naran NH
Clin Chim Acta; 1992 Dec; 213(1-3):1-13. PubMed ID: 1477981
[TBL] [Abstract][Full Text] [Related]
18. [Thromboxane, beta-thromboglobulin and the degree of blood sugar control in type 1 diabetes mellitus].
Tanganelli I; Signorini AM; Gragnoli G
Boll Soc Ital Biol Sper; 1983 Jul; 59(7):897-902. PubMed ID: 6194801
[TBL] [Abstract][Full Text] [Related]
19. Relationship between fatty acid pattern and platelet aggregation in long-term insulin-dependent type I diabetics.
Schimke E; Hildebrandt R; Grzeskowiak B
Biomed Biochim Acta; 1988; 47(10-11):S274-7. PubMed ID: 3248113
[TBL] [Abstract][Full Text] [Related]
20. Effects of fish oil supplements in NIDDM subjects. Controlled study.
Hendra TJ; Britton ME; Roper DR; Wagaine-Twabwe D; Jeremy JY; Dandona P; Haines AP; Yudkin JS
Diabetes Care; 1990 Aug; 13(8):821-9. PubMed ID: 2209315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
